Results 51 to 60 of about 4,554 (207)

Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The liver is not merely a passive recipient of disseminated tumor cells, but a unique metastatic organ shaped by anatomical, metabolic, and immunological characteristics that support tumor colonization. Increasing evidence indicates that colorectal cancer liver metastasis development is driven by dynamic interactions between tumor intrinsic programs ...
Jialiang Fan   +10 more
wiley   +1 more source

Ablative radiotherapy in castration‐resistant prostate cancer

open access: yesBJU International, Volume 138, Issue 4, Page 659-665, October 2026.
Objective To prove the oncological benefit of ablative radiotherapy in patients with up to five metastases from castration‐resistant prostate cancer (CRPC) a single‐centre randomised trial was initiated. Patients and Methods This monocentric, randomised, phase II clinical trial enrolled patients with up to five prostate‐specific membrane antigen ...
Tobias Hölscher   +9 more
wiley   +1 more source

Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread

open access: yesFrontiers in Oncology, 2019
Myxopapillary ependymomas are a slow-growing, grade I type glial tumor in the lumbosacral region. More rarely, they can present as extradural, subcutaneous sacrococcygeal, or perisacral masses, and it is under these circumstances that they are more ...
Kristen A. Batich   +21 more
doaj   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1368-1381, September 2026.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya   +2 more
wiley   +1 more source

Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)

open access: yesRadiation Oncology
Introduction Stage IV non-small cell lung carcinoma (NSCLC) with oligometastases is potentially curable by radical treatment. This study aimed to evaluate the efficacy and safety of chemoradiotherapy (CRT) for thoracic disease, including the primary ...
Takaaki Tokito   +16 more
doaj   +1 more source

Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature

open access: yesFuture Science OA, 2020
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT) for lung oligometastases. A systematic review of literature with a priori selection criteria was conducted on articles on the treatment of pulmonary ...
Francesco Londero   +8 more
doaj   +1 more source

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China

open access: yesFrontiers in Oncology, 2022
ObjectiveTo assess the efficacy and safety of stereotactic body radiation therapy (SBRT) in managing oligometastases of prostate cancer. Moreover, it is the largest-to-date study in China to report the safety and efficacy of SBRT by CyberKnife for ...
Chenyang Xu   +9 more
doaj   +1 more source

Validation of the 9th Edition of the Tumor‐Node‐Metastasis Staging System for Non‐Metastatic Nasopharyngeal Carcinoma: A Multicenter Retrospective Analysis From High‐Incidence Regions

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Objective To evaluate and compare the prognostic value of the 8th and 9th editions of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system in patients with non‐metastatic nasopharyngeal carcinoma (NPC).
Yongquan Wei   +12 more
wiley   +1 more source

A multi-national report on stereotactic body radiotherapy for oligometastases: patient selection and follow-up*

open access: yes, 2016
Aims Stereotactic body radiotherapy (SBRT) for oligometastases is increasingly used with few evidenced-based guidelines. We conducted a survey to determine patient selection and follow-up practice patterns.Materials and methods Seven institutions from US,
Foote, Matthew C.   +15 more
core   +1 more source

New Strategies in Stereotactic Radiotherapy for Oligometastases [PDF]

open access: yesClinical Cancer Research, 2015
Abstract Patients with metastatic solid tumors are usually treated with palliative intent. Systemic therapy and palliative radiation are often used, with the goals of prolonging survival or maintaining quality of life, but not of cure.
David A, Palma   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy